Clinical trial
Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response
NCT05371860
Study timeline
Study start (estimated)2023-07-01Date precision: month
Registry last updated2023-09-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
HER2-positive Breast Cancerunresolved
Interventions
Sponsors & collaborators
Armando Giulianolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05371860 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.